Pfizer is said to divest remaining stake in BioNTech

BioNTech (BNTX) stock slips as Pfizer (PFE) plans to sell its remaining stake in the COVID-19 vaccine developer in a ...

Lifelong drugs for autoimmune diseases don’t work well. Now scientists are trying something new

There's a new frontier in treating autoimmune diseases. Today's treatments tamp down the friendly fire but don't fix what's ...
TipRanks on MSN

Moderna Approves Stock Option Exchange Program

The first was a one-time stock option exchange program for non-Executive Committee employees, which received significant support from stockholders. The second proposal allowed for the adjournment of ...
Investor's Business Daily on MSN

Korro Bio Plummets To A Record Low On A Big Setback In RNA-Editing

Korro BioKRRO stock plummeted Thursday after its RNA-editing drug failed to pass muster in patients with a rare lung and ...
Ecofin Agency

In a First in 50 Years, Clinical Trial Begins for a New Oral Cholera Vaccine

Biovac starts first oral cholera vaccine trial in 50 years amid Africa surge Africa accounts for 82% of global cholera cases; vaccine stockpiles strained New Cape Town lab backs AU goal to produce 60% ...